<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17224" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Adrenal Crisis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Elshimy</surname>
            <given-names>Ghada</given-names>
          </name>
          <aff>University of Arizona</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chippa</surname>
            <given-names>Venu</given-names>
          </name>
          <aff>Indiana university</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaur</surname>
            <given-names>Jasleen</given-names>
          </name>
          <aff>HealthPartners, Minneapolis</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jeong</surname>
            <given-names>Jordan M.</given-names>
          </name>
          <aff>Coney Island Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ghada Elshimy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venu Chippa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jasleen Kaur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jordan Jeong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17224.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>An adrenal crisis is an acute, life-threatening condition triggered by various factors, occurring in individuals with either known or unknown adrenal insufficiency. Due to its rare occurrence,&#x000a0;this condition remains inadequately recognized, leading to substantial treatment delays and elevated mortality rates.&#x000a0;This activity comprehensively reviews the diagnosis, presentation, pathophysiology, precipitating factors, and management of an adrenal crisis. This activity provides a comprehensive review of patient education strategies and the prevention of adrenal crises. In addition, this activity highlights the essential role of the interprofessional healthcare team in treating patients with adrenal crises to enhance the overall treatment outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the risk factors and clinical signs of adrenal crises in patients with known or suspected adrenal insufficiency.</p></list-item><list-item><p>Implement evidence-based guidelines for the timely diagnosis and treatment of adrenal crisis, including appropriate use of glucocorticoid therapy and fluid resuscitation.</p></list-item><list-item><p>Apply stress dosing guidelines for glucocorticoid replacement therapy during stressful situations, such as trauma, surgery, and severe illness, to prevent adrenal crisis.</p></list-item><list-item><p>Collaborate with the interprofessional&#x000a0;healthcare team to monitor and educate patients with adrenal insufficiency and implement patient-specific prevention strategies to avoid adrenal crises.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17224&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17224">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17224.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Adrenal crisis, or Addisonian crisis, is a severe, life-threatening condition characterized by acute adrenal insufficiency. This condition has a substantial mortality rate of 0.5 per 100 patient-years&#x000a0;and remains a significant cause of death in individuals with adrenal insufficiency.<xref ref-type="bibr" rid="article-17224.r1">[1]</xref>&#x000a0;Patients&#x000a0;can experience rapid deterioration without timely intervention, potentially resulting in fatal outcomes either at home or shortly after hospital admission.</p>
        <p>This endocrine emergency arises when the production of cortisol, the primary glucocorticoid (GC) adrenal hormone, is inadequate either due to internal or external factors. Early recognition and immediate intervention are crucial for&#x000a0;saving a patient's life and&#x000a0;improving survival rates.<xref ref-type="bibr" rid="article-17224.r2">[2]</xref>&#x000a0;</p>
        <p>Clinicians must distinguish between adrenal insufficiency and adrenal crisis, as the latter can be fatal if not treated promptly. Despite the well-described characteristics of this condition, its recognition can be challenging, resulting in delayed treatment initiation and&#x000a0;increased&#x000a0;morbidity and mortality rates.<xref ref-type="bibr" rid="article-17224.r3">[3]</xref>&#x000a0;</p>
        <p>Essential measures in preventing adrenal crises include educating patients and their families about sick day rules and ensuring the availability of intramuscular hydrocortisone at home.<xref ref-type="bibr" rid="article-17224.r4">[4]</xref></p>
        <p>The ongoing debate among experts in the field has led to a lack of consensus on the definition of adrenal crisis. Several expert reviews have tried to establish their definitions of adrenal crisis. Among the numerous descriptions available for this condition, we will adhere to the one put forth by Rushworth et al in 2019 for this activity, as mentioned below.<xref ref-type="bibr" rid="article-17224.r5">[5]</xref></p>
        <p>Adrenal crisis is defined by an&#x000a0;acute deterioration in health status that is associated with the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Absolute hypotension with a systolic blood pressure &#x0003c;100 mm Hg.</p>
          </list-item>
          <list-item>
            <p>Relative hypotension with a systolic blood pressure &#x02265;20 mm Hg lower than the patient's usual baseline.</p>
          </list-item>
        </list>
        <p>Typically, these features should improve and resolve within 1 to 2 hours after administering parenteral GCs, marked by a significant reduction in hypotension within the first hour.&#x000a0;Furthermore, there should be a gradual improvement in patients' clinical symptoms over the subsequent 2 hours.<xref ref-type="bibr" rid="article-17224.r5">[5]</xref></p>
      </sec>
      <sec id="article-17224.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>History of Adrenal Crisis</bold>
</p>
        <p>In 1855, Thomas Addison's pioneering work provided the earliest description of adrenal insufficiency, marking a significant milestone in comprehending this condition.<xref ref-type="bibr" rid="article-17224.r6">[6]</xref> The discovery of cortisone by Hench, Kendall, and Reichstein in the late 1940s revolutionized the treatment of adrenal insufficiency, leading to a remarkable enhancement in the life expectancy of individuals affected by this condition.<xref ref-type="bibr" rid="article-17224.r7">[7]</xref><xref ref-type="bibr" rid="article-17224.r8">[8]</xref>&#x000a0;</p>
        <p>In the 1930s, tuberculosis was the most prevalent cause of this condition, accounting for approximately 70% of cases. In recent times, autoimmune adrenalitis, or Addison's disease, has emerged as the leading cause of primary adrenal insufficiency in developed countries. In contrast, tuberculosis remains the leading cause of adrenal insufficiency in developing countries.<xref ref-type="bibr" rid="article-17224.r9">[9]</xref></p>
        <p>
<bold>Precipitating Factors for Adrenal Crisis</bold>
</p>
        <p>Acute adrenal crisis can be the&#x000a0;initial presentation of&#x000a0;undiagnosed adrenal insufficiency, potentially occurring in up to 50% of patients who have already been diagnosed with this condition.<xref ref-type="bibr" rid="article-17224.r10">[10]</xref><xref ref-type="bibr" rid="article-17224.r11">[11]</xref><xref ref-type="bibr" rid="article-17224.r12">[12]</xref>&#x000a0;In a previous study, approximately 10% of patients exhibited no identifiable cause for their adrenal crisis.<xref ref-type="bibr" rid="article-17224.r13">[13]</xref>&#x000a0;The primary causes of adrenal crises are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial, mycobacterial, fungal, parasitic, or viral, such as COVID-19, infections&#x000a0;<xref ref-type="bibr" rid="article-17224.r13">[13]</xref><xref ref-type="bibr" rid="article-17224.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Gastrointestinal and flu-like illnesses&#x000a0;<xref ref-type="bibr" rid="article-17224.r5">[5]</xref><xref ref-type="bibr" rid="article-17224.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Trauma, pregnancy, childbirth, surgery, exposure to extreme hot or cold weather, or other stressful situations</p>
          </list-item>
          <list-item>
            <p>Significant emotional&#x000a0;distress&#x000a0;<xref ref-type="bibr" rid="article-17224.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Strenuous physical activity&#x000a0;<xref ref-type="bibr" rid="article-17224.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Nonadherence to GC replacement therapy&#x000a0;<xref ref-type="bibr" rid="article-17224.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Abrupt cessation of chronic GC therapy&#x000a0;<xref ref-type="bibr" rid="article-17224.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Thyrotoxicosis, as it accelerates cortisol metabolism.</p>
          </list-item>
          <list-item>
            <p>Levothyroxine therapy&#x000a0;initiation in a previously untreated case of adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>Antiadrenal medications, including mitotane, metyrapone, ketoconazole</p>
          </list-item>
          <list-item>
            <p>Anticancer medications, including immunotherapy with checkpoint inhibitors and tyrosine kinase inhibitors&#x000a0;<xref ref-type="bibr" rid="article-17224.r18">[18]</xref><xref ref-type="bibr" rid="article-17224.r19">[19]</xref><xref ref-type="bibr" rid="article-17224.r20">[20]</xref><xref ref-type="bibr" rid="article-17224.r21">[21]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17224.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Determining the exact frequency of adrenal crises in the general population poses a significant challenge. Patients with adrenal insufficiency have been estimated to experience an adrenal crisis in 6% to 8% of cases annually.<xref ref-type="bibr" rid="article-17224.r15">[15]</xref><xref ref-type="bibr" rid="article-17224.r22">[22]</xref>&#x000a0;The incidence of adrenal crises remains high even among patients who have received extensive education on managing and preventing adrenal insufficiency.<xref ref-type="bibr" rid="article-17224.r13">[13]</xref>&#x000a0;A study revealed a 6% mortality rate associated with adrenal crises among this well-informed group of patients.<xref ref-type="bibr" rid="article-17224.r13">[13]</xref>&#x000a0;The annual frequency of adrenal crisis in patients with Addison's disease remains&#x000a0;at 8%.<xref ref-type="bibr" rid="article-17224.r23">[23]</xref></p>
        <p>
<bold>Risk Factors for Adrenal Crisis</bold>
</p>
        <p>The risk factors associated with adrenal crisis are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>A known history of adrenal insufficiency or previous adrenal crisis</p>
          </list-item>
          <list-item>
            <p>Primary adrenal insufficiency diagnosis, which carries a higher risk than secondary adrenal insufficiency&#x000a0;<xref ref-type="bibr" rid="article-17224.r10">[10]</xref><xref ref-type="bibr" rid="article-17224.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Ongoing GC therapy, including topical and inhalation forms, which&#x000a0;poses a risk for an adrenal crisis due to the potential suppression of the hypothalamic-pituitary-adrenal (HPA) axis, if abruptly discontinued</p>
          </list-item>
          <list-item>
            <p>Medications, including levothyroxine, phenytoin, phenobarbital, rifampin, carbamazepine, St John's wort, ketoconazole, etomidate, and fluconazole, which&#x000a0;affect cortisol metabolism or reduce its production&#x000a0;<xref ref-type="bibr" rid="article-17224.r25">[25]</xref><xref ref-type="bibr" rid="article-17224.r26">[26]</xref><xref ref-type="bibr" rid="article-17224.r27">[27]</xref><xref ref-type="bibr" rid="article-17224.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Anticoagulation agents, which increase the risk of adrenal hemorrhage</p>
          </list-item>
          <list-item>
            <p>Additional medications, including&#x000a0;megestrol acetate and medroxyprogesterone&#x000a0;<xref ref-type="bibr" rid="article-17224.r29">[29]</xref><xref ref-type="bibr" rid="article-17224.r30">[30]</xref><xref ref-type="bibr" rid="article-17224.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>Pregnancy, particularly during the third trimester&#x000a0;<xref ref-type="bibr" rid="article-17224.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p>Advanced age&#x000a0;<xref ref-type="bibr" rid="article-17224.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>The presence&#x000a0;of comorbidities&#x000a0;<xref ref-type="bibr" rid="article-17224.r10">[10]</xref><xref ref-type="bibr" rid="article-17224.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Patients with type 1 diabetes<xref ref-type="bibr" rid="article-17224.r5">[5]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Adrenal metastasis or&#x000a0;adrenal hemorrhage&#x000a0;<xref ref-type="bibr" rid="article-17224.r33">[33]</xref><xref ref-type="bibr" rid="article-17224.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p>Polyglandular autoimmune syndromes 1 and 2&#x000a0;<xref ref-type="bibr" rid="article-17224.r35">[35]</xref><xref ref-type="bibr" rid="article-17224.r36">[36]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17224.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of adrenal crisis is not fully understood; however, examining the functions of GCs can provide insight into clinical manifestations. GCs exhibit various roles in stress responses by demonstrating permissive, suppressive, stimulatory, and preparative effects. Although&#x000a0;these functions have been described in greater detail in a different activity, a concise overview is provided&#x000a0;below.<xref ref-type="bibr" rid="article-17224.r37">[37]</xref></p>
        <p>
<bold>Cardiovascular System</bold>
</p>
        <p>GCs have a permissive effect on the functioning of adrenergic receptors in the heart and vasculature. Without GCs, catecholamines cannot exert their full impact on these receptors.<xref ref-type="bibr" rid="article-17224.r38">[38]</xref>&#x000a0;Consequently, during an adrenal crisis, patients often experience hypotension, and in severe cases, they may develop profound shock that remains unresponsive to fluid resuscitation and vasopressor therapy.</p>
        <p>
<bold>Immune System</bold>
</p>
        <p>Infectious or noninfectious stressors can trigger the activation of the immune system, leading to an elevated release of cytokines. Interleukin (IL)-1, IL-2, IL-6, tumor necrosis factor (TNF)-&#x003b1;, and TNF-&#x003b3; have pivotal roles in this immune response. This immune activation subsequently leads to the activation of the HPA axis, resulting in elevated GC levels.<xref ref-type="bibr" rid="article-17224.r39">[39]</xref><xref ref-type="bibr" rid="article-17224.r40">[40]</xref>&#x000a0;</p>
        <p>GCs mitigate immune response by inhibiting cytokine production, release, and effects, thereby playing a crucial role in immune regulation.<xref ref-type="bibr" rid="article-17224.r41">[41]</xref><xref ref-type="bibr" rid="article-17224.r42">[42]</xref> During an adrenal crisis, any significant stressor can trigger an uncontrolled cytokine response, such as inflammation, resulting in fever, widespread vasodilation, and heightened capillary permeability. This can result in&#x000a0;hypovolemia and shock as a consequence of fluid shifting from capillaries into tissues, thereby contributing to the development of hypovolemic shock.</p>
        <p>To sum up, during an adrenal crisis, the dysregulation of the immune response, marked by an excessive cytokine release, can result in systemic inflammation, fever, vasodilation, capillary leakage, hypovolemia, and shock.</p>
        <p>
<bold>Intravascular Volume</bold>
</p>
        <p>GCs can potentially suppress the expression and secretion of antidiuretic hormone (ADH) in the hypothalamic neurons.<xref ref-type="bibr" rid="article-17224.r43">[43]</xref><xref ref-type="bibr" rid="article-17224.r44">[44]</xref> During an adrenal crisis, there is an upsurge in the activity of ADH, leading to increased diuresis and volume depletion.</p>
        <p>
<bold>Glucose Homeostasis</bold>
</p>
        <p>GCs increase glucose levels in response to stress through various mechanisms, including promoting glycogenolysis and stimulating gluconeogenesis.<xref ref-type="bibr" rid="article-17224.r45">[45]</xref>&#x000a0;In addition, GCs also&#x000a0;induce insulin resistance, which reduces glucose uptake by the peripheral cells.<xref ref-type="bibr" rid="article-17224.r45">[45]</xref>&#x000a0;During an adrenal crisis, the deficiency of GCs hinders these normal stress responses. As a result of the GC-deficient state, hypoglycemia can occur due to insufficient glucose production and improved peripheral utilization.</p>
        <p>
<bold>Appetite&#x000a0;Regulation</bold>
</p>
        <p>Corticotropin-releasing hormone (CRH) is a potent appetite suppressant in response to stress.<xref ref-type="bibr" rid="article-17224.r46">[46]</xref>&#x000a0;GCs are potent inhibitors of CRH release that can lead to increased appetite.<xref ref-type="bibr" rid="article-17224.r43">[43]</xref> During an adrenal crisis, the release of CRH remains uninhibited in the GC-deficient state and leads to anorexia.</p>
        <p>
<bold>Electrolyte Disturbances</bold>
</p>
        <p>Primary adrenal insufficiency causes mineralocorticoid deficiency due to direct destruction of the adrenal cortex. However, the cortex remains intact in secondary and tertiary adrenal insufficiency. The renin-angiotensin-aldosterone system regulates aldosterone production and secretion.<xref ref-type="bibr" rid="article-17224.r47">[47]</xref>&#x000a0;An isolated deficiency of adrenocorticotropic hormone (ACTH) secretion observed in secondary or tertiary adrenal insufficiency does not significantly affect aldosterone levels.<xref ref-type="bibr" rid="article-17224.r48">[48]</xref><xref ref-type="bibr" rid="article-17224.r47">[47]</xref>&#x000a0;In primary adrenal insufficiency, aldosterone deficiency leads to volume loss, hyponatremia, and hyperkalemia.<xref ref-type="bibr" rid="article-17224.r12">[12]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17224.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The most prevalent clinical manifestations of adrenal crises include weakness, severe fatigue, unintentional weight loss, nausea, vomiting, abdominal pain, reduced appetite, back or limb pain, dizziness, somnolence, confusion, and loss of consciousness.<xref ref-type="bibr" rid="article-17224.r5">[5]</xref><xref ref-type="bibr" rid="article-17224.r49">[49]</xref>&#x000a0;</p>
        <p>In children, adrenal crises can manifest as weight loss with failure to thrive and are accompanied by other features, such as hypoglycemic crises, which may result in seizures. Less frequently observed presentations in individuals of all age groups include clinical scenarios resembling surgical emergencies, such as an acute abdomen, and symptoms, such as salt cravings, amenorrhea, loss of libido, and depression.&#x000a0;</p>
        <p>Assessing&#x000a0;a patient's vital signs when evaluating for an adrenal crisis&#x000a0;is essential. Patients experiencing an adrenal crisis may&#x000a0;exhibit several symptoms, including fever, tachycardia, and orthostatic hypotension.<xref ref-type="bibr" rid="article-17224.r49">[49]</xref> During physical examination, patients may appear visibly unwell. Individuals with primary adrenal insufficiency might display signs such as skin and buccal mucosa hyperpigmentation and scarring.<xref ref-type="bibr" rid="article-17224.r50">[50]</xref></p>
        <p>When evaluating a patient suspected of adrenal crisis, it is crucial to conduct a comprehensive review of the patient's medical history and past surgical history. In addition, the healthcare practitioner should perform a comprehensive review of the patient's list of home medications and supplements.<xref ref-type="bibr" rid="article-17224.r51">[51]</xref></p>
        <p>Identifying&#x000a0;any precipitating factors that may trigger an adrenal crisis in individuals is essential.&#x000a0;Inquiring about&#x000a0;a history of long-term GC use is necessary because&#x000a0;abrupt cessation&#x000a0;or&#x000a0;acute illness in these patients can precipitate adrenal crises.<xref ref-type="bibr" rid="article-17224.r52">[52]</xref>. Evaluating&#x000a0;other autoimmune diseases in patients while obtaining their&#x000a0;history is crucial,&#x000a0;as individuals with autoimmune polyglandular endocrinopathy can manifest multiple autoimmune disorders. Furthermore, recurrent hypoglycemia in patients with type 1 diabetes on insulin can indicate adrenal insufficiency. Patients with adrenal crisis usually present with an unexplained shock&#x000a0;resistant to standard fluid resuscitation and vasopressor therapy.<xref ref-type="bibr" rid="article-17224.r53">[53]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17224.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>In the context of an adrenal crisis, there may be several laboratory abnormalities. However, the classic laboratory features that may be revealed include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyponatremia, resulting from mineralocorticoid deficiency</p>
          </list-item>
          <list-item>
            <p>Hyperkalemia, resulting from mineralocorticoid deficiency</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia, stemming from decreased gluconeogenesis and glycogenolysis</p>
          </list-item>
          <list-item>
            <p>Low or low normal ACTH levels, as observed in secondary adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>High or high normal ACTH levels, as observed in primary adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>Hypercalcemia, resulting from hypovolemia</p>
          </list-item>
          <list-item>
            <p>Elevated creatinine levels, attributed to prerenal failure</p>
          </list-item>
          <list-item>
            <p>Low aldosterone levels, due to mineralocorticoid deficiency in primary adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>High renin levels,&#x000a0;as typically seen in primary adrenal insufficiency due to increased urinary sodium loss and reduced blood volume</p>
          </list-item>
          <list-item>
            <p>Normocytic normochromic anemia, lymphocytosis, and eosinophilia, resulting from GC deficiency</p>
          </list-item>
          <list-item>
            <p>Increased thyroid-stimulating hormone (TSH) levels, owing&#x000a0;to coexisting hypothyroidism in autoimmune polyglandular endocrinopathy or the absence of cortisol's inhibitory effect on TSH production</p>
          </list-item>
        </list>
        <p>
<bold>Evaluation of Cortisol Levels</bold>
</p>
        <p>Treatment of adrenal crises should never be delayed to obtain blood work for etiological assessment. Prompt administration of hydrocortisone is of utmost importance in managing adrenal crises. However, if there is no anticipated delay in treatment, blood work can be done quickly before initiating hydrocortisone administration.</p>
        <p>Healthcare providers suggest the below-mentioned blood tests for the treatment of adrenal crises.</p>
        <list list-type="bullet">
          <list-item>
            <p>ACTH: High ACTH levels with low cortisol and aldosterone indicate&#x000a0;primary adrenal insufficiency, whereas low ACTH levels with low cortisol suggest secondary or tertiary adrenal insufficiency.</p>
          </list-item>
          <list-item>
            <p>Basic metabolic panel: A basic metabolic profile blood test, including glucose, should also be included in the recommended blood work.</p>
          </list-item>
          <list-item>
            <p>Other blood tests: Additional blood work includes determining cortisol, aldosterone, and renin levels.</p>
          </list-item>
        </list>
        <p>In&#x000a0;situations with uncertainty&#x000a0;regarding the diagnosis of adrenal crisis and borderline cortisol levels, performing&#x000a0;an ACTH stimulation test in the acute setting is not recommended until the patient's condition has stabilized.<xref ref-type="bibr" rid="article-17224.r54">[54]</xref></p>
      </sec>
      <sec id="article-17224.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The administration of GCs, specifically hydrocortisone, constitutes the definitive treatment for adrenal crisis.&#x000a0;In patients with known adrenal insufficiency, symptoms&#x000a0;consistent&#x000a0;with an adrenal crisis should be sufficient to&#x000a0;initiate&#x000a0;treatment. If a patient is medically unstable and is strongly suspected of adrenal insufficiency or crisis, stress dose steroids should be administered promptly.<xref ref-type="bibr" rid="article-17224.r55">[55]</xref>&#x000a0;The administrative dosing of stress dose steroids and fluid resuscitation differs in children from adults (see <bold>Table 1</bold>).&#x000a0;</p>
        <table-wrap id="article-17224.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1. Guidelines for Managing Adrenal Crisis During Emergency</title>
          </caption>
          <table style="height: 200px; width: 800px; border-color: black;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 79px; height: 13px;" rowspan="1" colspan="1">&#x000a0;<bold>Age Groups</bold></td>
                <td style="width: 384.422px; height: 13px;" rowspan="1" colspan="1">
<bold>Stress Dosing</bold>
</td>
                <td style="width: 221.578px; height: 13px;" rowspan="1" colspan="1">
<bold>Fluid Resuscitation</bold>
</td>
              </tr>
              <tr style="height: 52px;">
                <td style="width: 79px; height: 52px;" rowspan="1" colspan="1">
<bold>Adults</bold>
</td>
                <td style="width: 384.422px; height: 52px;" rowspan="1" colspan="1">
<p>The recommended treatment regimen includes administering an initial dose of 100 mg of hydrocortisone&#x000a0;through intravenous or intramuscular (IV/IM) bolus injection. This is followed by administering an additional 200 mg of hydrocortisone as IM or IV&#x000a0;over the next 24 hours, with a dosage of 50 mg every 6 hours or as a continuous infusion.<xref ref-type="bibr" rid="article-17224.r5">[5]</xref></p>
</td>
                <td style="width: 221.578px; height: 52px;" rowspan="1" colspan="1">
<p>The suggested treatment approach for hypoglycemia is administering either 1&#x000a0;L of normal saline or 5% dextrose in 1 L of normal saline, followed by maintenance fluids.<xref ref-type="bibr" rid="article-17224.r5">[5]</xref></p>
</td>
              </tr>
              <tr style="height: 77px;">
                <td style="width: 79px; height: 77px;" rowspan="1" colspan="1">
<bold>Children</bold>
</td>
                <td style="width: 384.422px; height: 77px;" rowspan="1" colspan="1">
<p>Hydrocortisone dosage is initially calculated as 50 to 100 mg/m&#x000b2; of body surface area.&#x000a0;This is followed by an additional 50 to 100 mg/m&#x000b2; over the next 24 hours, administered as IM/IV, divided into equal doses every 6 hours, or as a continuous infusion.<xref ref-type="bibr" rid="article-17224.r27">[27]</xref><xref ref-type="bibr" rid="article-17224.r56">[56]</xref></p>
</td>
                <td style="width: 221.578px; height: 77px;" rowspan="1" colspan="1">
<p>The suggested treatment regimen is administering a normal saline bolus at 20 mL/kg of body weight, with repeated doses up to 60 mL/kg within the first hour. If hypoglycemia is present, additional dextrose should be considered at a dose of 0.5 to 1 g/kg.<xref ref-type="bibr" rid="article-17224.r27">[27]</xref></p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Recent evidence indicates that continuous infusion is a superior delivery method for hydrocortisone in the management of adrenal crises when compared to intermittent boluses.<xref ref-type="bibr" rid="article-17224.r57">[57]</xref>&#x000a0;Continuous hydrocortisone infusion has shown better maintenance of cortisol levels within the therapeutic range.</p>
        <p>In cases of adrenal crisis, involving an endocrinologist as soon as possible is crucial to ensure appropriate management of the condition and guidance in patient care.</p>
        <p>Once there is clinical improvement, initiating a gradual tapering of steroids is advisable.<xref ref-type="bibr" rid="article-17224.r58">[58]</xref> This approach helps prevent abrupt discontinuation and enables a smoother transition to lower doses.&#x000a0;</p>
        <p>The necessity for mineralocorticoid replacement should be assessed individually and in consultation with an endocrinologist. If the GC doses administered to patients exceed 50 mg, mineralocorticoid replacement is unnecessary.<xref ref-type="bibr" rid="article-17224.r59">[59]</xref></p>
        <p>In&#x000a0;situations where&#x000a0;hydrocortisone is unavailable,&#x000a0;alternative parenteral GCs can be considered, as mentioned below.<xref ref-type="bibr" rid="article-17224.r5">[5]</xref><xref ref-type="bibr" rid="article-17224.r27">[27]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Prednisolone: This can be a preferred alternative treatment, administered as an initial bolus of 25 mg and followed by 2 additional 25 mg doses within the first 24 hours. Subsequently, this regimen should be continued with a daily dose of 50 mg of prednisone.</p>
          </list-item>
          <list-item>
            <p>Methylprednisolone: This can be administered at a dosage of 40 mg every 24 hours.</p>
          </list-item>
          <list-item>
            <p>Dexamethasone: This is the least preferred alternative treatment, with a recommended dosage of 4 mg every 24 hours.</p>
          </list-item>
        </list>
        <p>In patients with an infectious process as the precipitating event for adrenal crisis, prompt administration of appropriate antibiotics is necessary to address the underlying infection.&#x000a0;</p>
      </sec>
      <sec id="article-17224.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>An adrenal crisis is rarely an&#x000a0;isolated event, and the&#x000a0;differential diagnosis may be comprehensive, depending on the presentation and underlying etiology. Although symptoms such as altered mental status, abdominal pain, nausea, vomiting, and fever are frequently encountered during presentations, hypotension typically remains the most significant feature. An adrenal crisis should be considered the primary differential diagnosis for patients with a known history of adrenal insufficiency and experiencing related symptoms.<xref ref-type="bibr" rid="article-17224.r60">[60]</xref>&#x000a0;</p>
        <p>Further investigation&#x000a0;is necessary to determine the underlying cause of the adrenal crisis. This assessment may encompass the evaluation for conditions such as sepsis, septic shock, circulatory shock, myxedema coma, infection, trauma, physical or emotional stress, myocardial infarction, and other potential triggers. In patients without a known adrenal pathology and exhibiting hypotension resistant to fluid administration and vasopressor support, the diagnosis of adrenal crisis should be strongly considered.<xref ref-type="bibr" rid="article-17224.r4">[4]</xref></p>
      </sec>
      <sec id="article-17224.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Despite the potential for successful treatment with prompt administration of GCs, the associated mortality rate remains unacceptably high for adrenal crisis, which is a rare diagnosis. Therefore, due to its rarity,&#x000a0;many healthcare professionals may have limited familiarity with the presentation and management of adrenal crises. A retrospective study in the United Kingdom revealed that adrenal crisis contributed to 10% of the deaths in patients with primary and secondary adrenal insufficiency.<xref ref-type="bibr" rid="article-17224.r61">[61]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17224.s11" sec-type="Complications">
        <title>Complications</title>
        <p>An adrenal crisis can result in fatal outcomes, even with timely recognition and appropriate treatment.<xref ref-type="bibr" rid="article-17224.r2">[2]</xref> Besides the risk of death, adrenal crisis is associated with other potential complications. Electrolyte abnormalities, such as hyponatremia, hyperkalemia, and hypoglycemia, can lead to various complications, including seizures, arrhythmias, and coma.<xref ref-type="bibr" rid="article-17224.r60">[60]</xref> If left untreated, hypotension can lead to hypoperfusion, potentially resulting in multiple organ failure. Furthermore, the precipitating disease or event that triggered the adrenal crisis can introduce additional complications.<xref ref-type="bibr" rid="article-17224.r50">[50]</xref></p>
      </sec>
      <sec id="article-17224.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients presenting with an adrenal crisis often require a critical care evaluation and consultation due to the severity of their condition. Common manifestations such as hypotension, altered mental status, and cardiovascular collapse necessitate additional care and monitoring. Treatment in the acute care setting may involve using vasopressors, fluid resuscitation, antibiotics administration, and&#x000a0;targeted management, depending on the precipitating etiology of the adrenal crisis.</p>
        <p>On suspecting an adrenal crisis in a patient, seeking an emergent endocrinology consultation is imperative. This consultation can aid in confirming the diagnosis, tailoring the appropriate administration of corticosteroids, and managing any underlying endocrine disorders in long-term treatment during the inpatient and outpatient phases of care.</p>
      </sec>
      <sec id="article-17224.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>More than 50% of patients with adrenal crisis do not have a prior diagnosis of adrenal insufficiency. Therefore,&#x000a0;it is crucial to&#x000a0;enhance the competence of healthcare professionals through education regarding the diagnosis and use of stress dose steroids to manage adrenal crises effectively.<xref ref-type="bibr" rid="article-17224.r60">[60]</xref></p>
        <p>Patients should be educated by their healthcare providers based on the guidelines mentioned below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients should&#x000a0;be aware of the sick day rules, which involve doubling or tripling their daily oral dose of GCs during an acute illness. This helps mimic the physiological response of increased cortisol levels under stressful situations.<xref ref-type="bibr" rid="article-17224.r17">[17]</xref>
<list list-type="bullet"><list-item><p>For a fever exceeding 38 &#x000b0;C, doubling the oral corticosteroid dose is recommended.</p></list-item><list-item><p>For a fever exceeding 39 &#x000b0;C, tripling the oral corticosteroid dose is recommended.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients should know&#x000a0;how to administer stress doses during&#x000a0;stressful situations, including trauma, surgery, major procedures, and severe illness (see&#x000a0;<bold>Table 2</bold>). In&#x000a0;cases&#x000a0;of significant emotional stress, such as the death of a loved one or the anticipation of a significant upcoming examination, patients are recommended to take an additional dose of 10 mg of hydrocortisone to help manage the situation.<xref ref-type="bibr" rid="article-17224.r17">[17]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients should be&#x000a0;educated about the&#x000a0;signs and symptoms of adrenal insufficiency to facilitate early recognition and management. Some common signs and symptoms include nausea, vomiting, abdominal pain, unintentional weight loss, dizziness, confusion, low blood glucose, fever, and a diminished sense of well-being.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients with adrenal insufficiency should be informed that wearing a medical alert bracelet or necklace is paramount for managing this condition. This simple yet crucial accessory can provide essential information to healthcare providers during emergencies, ensuring the prompt delivery of utmost and appropriate care.<xref ref-type="bibr" rid="article-17224.r27">[27]</xref><xref ref-type="bibr" rid="article-17224.r58">[58]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients should also ensure they have additional emergency supplies at home, which should be readily available and can be utilized as and when required.<xref ref-type="bibr" rid="article-17224.r62">[62]</xref>&#x000a0;An emergency kit should include injectable vials of 100 mg hydrocortisone sodium succinate or 4 mg dexamethasone,&#x000a0;0.9% sterile normal saline vials, and syringes.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients should have a steroid card&#x000a0;that provides information and instructions for managing an adrenal crisis. This card should be easily accessible and readily available, especially in emergencies or when seeking medical care at a hospital or healthcare facility. Maintaining this card is crucial for patients as healthcare professionals at these facilities may not be familiar with managing adrenal crises. The steroid card should clearly outline the recommended dosing information for&#x000a0;GC administration during an adrenal crisis. The recommended dosage is&#x000a0;100 mg of hydrocortisone administered IV/IM, followed by an additional 200 mg of hydrocortisone&#x000a0;over the next 24 hours. This should also be administered IM/IV in equally divided doses of 50 mg every 6 hours.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients should regularly schedule follow-up appointments with an endocrinologist, which is essential for monitoring their condition, optimizing treatment, and discussing stress dosing as needed. The recommended frequency of follow-up is annually for adults and every 3 to 6 months for children.</p>
          </list-item>
        </list>
        <table-wrap id="article-17224.table1" position="float" orientation="portrait">
          <caption>
            <title>Table 2.&#x000a0;Strategies for Adrenal Crisis Prevention</title>
          </caption>
          <table style="height: 500px; width: 800px; border-color: black;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 232.203px; height: 13px;" rowspan="1" colspan="1">
<bold>Stressors&#x000a0;</bold>
</td>
                <td style="width: 483.797px; height: 13px;" rowspan="1" colspan="1">
<bold>Dosage Adjustments</bold>
</td>
              </tr>
              <tr style="height: 40px;">
                <td style="width: 232.203px; height: 40px;" rowspan="1" colspan="1">Infection with fever &#x0003e;38&#x000a0;&#x000b0;C <xref ref-type="bibr" rid="article-17224.r5">[5]</xref><xref ref-type="bibr" rid="article-17224.r17">[17]</xref></td>
                <td style="width: 483.797px; height: 40px;" rowspan="1" colspan="1">Patients should double their dose of oral corticosteroids until recovery and then gradually decrease it&#x000a0;to the baseline dose in 2 days.</td>
              </tr>
              <tr style="height: 40px;">
                <td style="width: 232.203px; height: 40px;" rowspan="1" colspan="1">Infection with fever &#x0003e;39&#x000a0;&#x000b0;C <xref ref-type="bibr" rid="article-17224.r5">[5]</xref><xref ref-type="bibr" rid="article-17224.r17">[17]</xref></td>
                <td style="width: 483.797px; height: 40px;" rowspan="1" colspan="1">Patients should triple&#x000a0;the dose of oral corticosteroids until recovery and then gradually decrease it&#x000a0;to the baseline dose in 2 days.</td>
              </tr>
              <tr style="height: 40px;">
                <td style="width: 232.203px; height: 40px;" rowspan="1" colspan="1">Severe infections requiring admission to the intensive care unit (ICU) <xref ref-type="bibr" rid="article-17224.r5">[5]</xref></td>
                <td style="width: 483.797px; height: 40px;" rowspan="1" colspan="1">Patients should receive parenteral IV/IM or&#x000a0;subcutaneous (SQ) hydrocortisone administered at 50 to 100 mg every 6&#x000a0;to 12 hours until recovery.</td>
              </tr>
              <tr style="height: 68px;">
                <td style="width: 232.203px; height: 68px;" rowspan="1" colspan="1">Major surgery&#x000a0;<xref ref-type="bibr" rid="article-17224.r63">[63]</xref></td>
                <td style="width: 483.797px; height: 68px;" rowspan="1" colspan="1">Patients should receive&#x000a0;parental (IV/IM/SQ) hydrocortisone administered at a dose of 100 mg&#x000a0;during the induction of anesthesia, followed by 50&#x000a0;to 100 mg every 6 to 12 hours until recovery.</td>
              </tr>
              <tr style="height: 54px;">
                <td style="width: 232.203px; height: 54px;" rowspan="1" colspan="1">Minor surgery or major dental surgery&#x000a0;<xref ref-type="bibr" rid="article-17224.r63">[63]</xref></td>
                <td style="width: 483.797px; height: 54px;" rowspan="1" colspan="1">
<p>Patients should administer&#x000a0;100 mg of hydrocortisone during the induction of anesthesia, followed by a double oral dose for 24 hours, and then gradually return to the baseline dose.</p>
</td>
              </tr>
              <tr style="height: 54px;">
                <td style="width: 232.203px; height: 54px;" rowspan="1" colspan="1">During labor&#x000a0;<xref ref-type="bibr" rid="article-17224.r63">[63]</xref></td>
                <td style="width: 483.797px; height: 54px;" rowspan="1" colspan="1">
<p>Patients should administer&#x000a0;100 mg of hydrocortisone at the onset of labor, followed by an additional 25 to 50 mg&#x000a0;every 6 hours, and then&#x000a0;gradually reduce the dose over the next 3 days.</p>
</td>
              </tr>
              <tr style="height: 40px;">
                <td style="width: 232.203px; height: 40px;" rowspan="1" colspan="1">Significant emotional stress, such as the death of a loved one or the anticipation of a significant upcoming examination&#x000a0;<xref ref-type="bibr" rid="article-17224.r17">[17]</xref></td>
                <td style="width: 483.797px; height: 40px;" rowspan="1" colspan="1">
<p>Patients should administer an additional 10 to 20 mg of hydrocortisone to their baseline dose.</p>
</td>
              </tr>
              <tr style="height: 27px;">
                <td style="width: 232.203px; height: 27px;" rowspan="1" colspan="1">Prolonged intensive&#x000a0;strenuous exercise&#x000a0;<xref ref-type="bibr" rid="article-17224.r17">[17]</xref></td>
                <td style="width: 483.797px; height: 27px;" rowspan="1" colspan="1">
<p>Patients should administer an additional 10 mg of hydrocortisone 30&#x000a0;to 60 minutes before exercise.</p>
</td>
              </tr>
              <tr style="height: 54.2001px;">
                <td style="width: 232.203px; height: 54.2001px;" rowspan="1" colspan="1">Dental procedure</td>
                <td style="width: 483.797px; height: 54.2001px;" rowspan="1" colspan="1">Patients should take an additional dose of hydrocortisone 1 hour before the procedure, followed by a double dose for the next 24 hours. Subsequently, they can return to their regular dosage.</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 232.203px; height: 13px;" rowspan="1" colspan="1">Minor procedure</td>
                <td style="width: 483.797px; height: 13px;" rowspan="1" colspan="1">No dosage adjustment is needed.</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-17224.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>An adrenal crisis should be suspected in patients who exhibit acute refractory shock despite receiving adequate fluid resuscitation and vasopressor support. Adrenal crises may be more frequently observed in older patients and individuals with comorbidities and concurrent endocrine disorders. Patients experiencing altered mental status in conjunction with endocrine disorders may face an increased mortality risk.</p>
        <p>Hyponatremia, hyperkalemia, or hypoglycemia, especially with hypotension, may indicate an adrenal crisis. Immediate administration of 100 mg hydrocortisone via IV/IM is crucial in suspected adrenal crisis treatment. Prompt initiation of GC therapy is essential for managing adrenal crises&#x000a0;and preventing further deterioration.</p>
      </sec>
      <sec id="article-17224.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective management of adrenal crises, particularly in the ICU, requires an interprofessional team approach due to the involvement of multiple organs and a high mortality rate.&#x000a0;The interprofessional healthcare team responsible for caring for patients and managing adrenal crises should include an intensivist, endocrinologist, ICU nurse, and pharmacist.</p>
        <p>ICU nurses are critical in monitoring vital signs, urine output, and hemodynamics of patients&#x000a0;experiencing adrenal crises.&#x000a0;Close observation and prompt recognition of changes or deterioration in a patient's condition are essential for early intervention and appropriate management. Patient education is a critical aspect of preventing adrenal crisis episodes. In collaboration with the multidisciplinary healthcare team, nurses should educate patients and their families about this condition and its potential complications and the importance of adhering to sick day rules.<xref ref-type="bibr" rid="article-17224.r58">[58]</xref></p>
        <p>Emphasis should be placed on avoiding the abrupt cessation of exogenous corticosteroids, as this is a common trigger for adrenal crisis. Patients should receive education about the importance of regular monitoring, recognizing signs of adrenal insufficiency, and making appropriate adjustments to their medication doses. The clinician and the pharmacist should educate patients about the adverse effects of corticosteroids. Furthermore, all patients with adrenal insufficiency should be encouraged to wear a medical alert bracelet or necklace that indicates their condition&#x000a0;during emergencies.<xref ref-type="bibr" rid="article-17224.r64">[64]</xref></p>
        <p>
<bold>Patient Outcomes</bold>
</p>
        <p>Despite receiving steroid replacement therapy, individuals who have experienced adrenal crises often face significant challenges in their quality of life. Studies have indicated that many individuals suffer from disabilities and are unable to work due to conditions such as depression and chronic fatigue, thereby leading to a poor quality of life.<xref ref-type="bibr" rid="article-17224.r65">[65]</xref>&#x000a0;</p>
        <p>Adrenal crises continue to maintain an unacceptably high mortality rate. Although the exact cause of mortality may not be apparent in all cases, it is believed to be attributed to respiratory infections, adverse cardiovascular events, and stroke.<xref ref-type="bibr" rid="article-17224.r1">[1]</xref></p>
        <p>Despite extensive efforts in patient education, the incidence of adrenal crisis&#x02013;related mortality remains significant. A study involving 423 participants reported an adrenal crisis&#x02013;related mortality rate as high as 6%.<xref ref-type="bibr" rid="article-17224.r13">[13]</xref>&#x000a0;In a previous study, patient satisfaction with managing adrenal crises in the emergency setting was&#x000a0;as low as 66%.<xref ref-type="bibr" rid="article-17224.r66">[66]</xref></p>
      </sec>
      <sec id="article-17224.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17224&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17224">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/adrenal-crisis-addisonian-crisis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17224">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17224/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17224">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17224.s17">
        <title>References</title>
        <ref id="article-17224.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rushworth</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Crises in Children: Perspectives and Research Directions.</article-title>
            <source>Horm Res Paediatr</source>
            <year>2018</year>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>341</fpage>
            <page-range>341-351</page-range>
            <pub-id pub-id-type="pmid">29874655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018!</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>164</fpage>
            <page-range>164-166</page-range>
            <pub-id pub-id-type="pmid">29716733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higham</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Olsson-Brown</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cooksley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Larkin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lorigan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morganstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Trainer</surname>
                <given-names>PJ</given-names>
              </name>
              <collab>Society for Endocrinology Clinical Committee</collab>
            </person-group>
            <article-title>SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy.</article-title>
            <source>Endocr Connect</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>G1</fpage>
            <page-range>G1-G7</page-range>
            <pub-id pub-id-type="pmid">29930025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puar</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Stikkelbroeck</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Smans</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Zelissen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hermus</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Crisis: Still a Deadly Event in the 21st Century.</article-title>
            <source>Am J Med</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>339.e1</fpage>
            <page-range>339.e1-9</page-range>
            <pub-id pub-id-type="pmid">26363354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rushworth</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Crisis.</article-title>
            <source>N Engl J Med</source>
            <year>2019</year>
            <month>Aug</month>
            <day>29</day>
            <volume>381</volume>
            <issue>9</issue>
            <fpage>852</fpage>
            <page-range>852-861</page-range>
            <pub-id pub-id-type="pmid">31461595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Upadhyay</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sudhindra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Trivedi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis of the adrenal gland: a case report and review of the literature of infections of the adrenal gland.</article-title>
            <source>Int J Endocrinol</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>876037</fpage>
            <pub-id pub-id-type="pmid">25165474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burns</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>The History of Cortisone Discovery and Development.</article-title>
            <source>Rheum Dis Clin North Am</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-14, vii</page-range>
            <pub-id pub-id-type="pmid">26611547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gidl&#x000f6;f</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thil&#x000e9;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>von D&#x000f6;beln</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ritz&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wedell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nordenstr&#x000f6;m</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.</article-title>
            <source>Lancet Diabetes Endocrinol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">24622265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nomura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Omori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takano</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for adrenal crisis in patients with adrenal insufficiency.</article-title>
            <source>Endocr J</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>745</fpage>
            <page-range>745-52</page-range>
            <pub-id pub-id-type="pmid">14709847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smans</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Van der Valk</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Hermus</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Zelissen</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Incidence of adrenal crisis in patients with adrenal insufficiency.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">26208266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleicken</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ventz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quinkler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients.</article-title>
            <source>Am J Med Sci</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>339</volume>
            <issue>6</issue>
            <fpage>525</fpage>
            <page-range>525-31</page-range>
            <pub-id pub-id-type="pmid">20400889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erichsen</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>L&#x000f8;v&#x000e5;s</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Skinningsrud</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Undlien</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Svartberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fougner</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Bollerslev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mella</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Erlich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Husebye</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>4882</fpage>
            <page-range>4882-90</page-range>
            <pub-id pub-id-type="pmid">19858318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Spinnler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fassnacht</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burger-Stritt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Milovanovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beuschlein</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Willenberg</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Quinkler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>100</volume>
            <issue>2</issue>
            <fpage>407</fpage>
            <page-range>407-16</page-range>
            <pub-id pub-id-type="pmid">25419882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heidarpour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vakhshoori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abbasi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shafie</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency in coronavirus disease 2019: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2020</year>
            <month>Aug</month>
            <day>24</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>134</fpage>
            <pub-id pub-id-type="pmid">32838801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Loeffler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bleicken</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Drechsler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Milovanovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fassnacht</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ventz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quinkler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>162</volume>
            <issue>3</issue>
            <fpage>597</fpage>
            <page-range>597-602</page-range>
            <pub-id pub-id-type="pmid">19955259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lousada</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Mendonca</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Bachega</surname>
                <given-names>TASS</given-names>
              </name>
            </person-group>
            <article-title>Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia.</article-title>
            <source>Arch Endocrinol Metab</source>
            <year>2021</year>
            <month>Nov</month>
            <day>03</day>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>488</fpage>
            <page-range>488-494</page-range>
            <pub-id pub-id-type="pmid">34283908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Extensive expertise in endocrinology. Adrenal crisis.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>172</volume>
            <issue>3</issue>
            <fpage>R115</fpage>
            <page-range>R115-24</page-range>
            <pub-id pub-id-type="pmid">25288693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kage</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyagawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kume</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagase</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iiri</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nangaku</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Makita</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency.</article-title>
            <source>Sci Rep</source>
            <year>2021</year>
            <month>Jun</month>
            <day>02</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>11617</fpage>
            <pub-id pub-id-type="pmid">34078988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joshi</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Whitelaw</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Palomar</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>85</volume>
            <issue>3</issue>
            <fpage>331</fpage>
            <page-range>331-9</page-range>
            <pub-id pub-id-type="pmid">26998595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elshimy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Correa</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer.</article-title>
            <source>J Investig Med High Impact Case Rep</source>
            <year>2020</year>
            <season>Jan-Dec</season>
            <volume>8</volume>
            <fpage>2324709620936808</fpage>
            <pub-id pub-id-type="pmid">32583692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lodish</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Clinical review: kinase inhibitors: adverse effects related to the endocrine system.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>98</volume>
            <issue>4</issue>
            <fpage>1333</fpage>
            <page-range>1333-42</page-range>
            <pub-id pub-id-type="pmid">23450053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rushworth</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Adrenal crises: perspectives and research directions.</article-title>
            <source>Endocrine</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>336</fpage>
            <page-range>336-345</page-range>
            <pub-id pub-id-type="pmid">27995500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Adrenal crisis in treated Addison's disease: a predictable but under-managed event.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>162</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-20</page-range>
            <pub-id pub-id-type="pmid">19776201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iwasaku</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shinzawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kimachi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawakami</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study.</article-title>
            <source>BMC Endocr Disord</source>
            <year>2017</year>
            <month>Sep</month>
            <day>11</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <pub-id pub-id-type="pmid">28893233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>May</month>
            <day>31</day>
            <volume>361</volume>
            <issue>9372</issue>
            <fpage>1881</fpage>
            <page-range>1881-93</page-range>
            <pub-id pub-id-type="pmid">12788587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bornstein</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Predisposing factors for adrenal insufficiency.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>May</month>
            <day>28</day>
            <volume>360</volume>
            <issue>22</issue>
            <fpage>2328</fpage>
            <page-range>2328-39</page-range>
            <pub-id pub-id-type="pmid">19474430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bornstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Barthel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Don-Wauchope</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Husebye</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Merke</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>101</volume>
            <issue>2</issue>
            <fpage>364</fpage>
            <page-range>364-89</page-range>
            <pub-id pub-id-type="pmid">26760044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shibata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kami</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kanda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Machida</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takeshita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miyakoshi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ueyama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morinaga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mutou</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide.</article-title>
            <source>Am J Hematol</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-5</page-range>
            <pub-id pub-id-type="pmid">11279645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orme</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Bond</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Humphrey</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Zacharin</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Downie</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Jamsen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Grapsas</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Ashley</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression.</article-title>
            <source>Cancer</source>
            <year>2003</year>
            <month>Jul</month>
            <day>15</day>
            <volume>98</volume>
            <issue>2</issue>
            <fpage>397</fpage>
            <page-range>397-405</page-range>
            <pub-id pub-id-type="pmid">12872362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naing</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Dewar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Leese</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Megestrol acetate therapy and secondary adrenal suppression.</article-title>
            <source>Cancer</source>
            <year>1999</year>
            <month>Sep</month>
            <day>15</day>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>1044</fpage>
            <page-range>1044-9</page-range>
            <pub-id pub-id-type="pmid">10491532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hellman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zumoff</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kream</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>The effect of medroxyprogesterone acetate on the pituitary-adrenal axis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1976</year>
            <month>May</month>
            <volume>42</volume>
            <issue>5</issue>
            <fpage>912</fpage>
            <page-range>912-7</page-range>
            <pub-id pub-id-type="pmid">178684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuen</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management.</article-title>
            <source>Endocrine</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>283</fpage>
            <page-range>283-92</page-range>
            <pub-id pub-id-type="pmid">23377701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tallis</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Rushworth</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency due to bilateral adrenal metastases - A systematic review and meta-analysis.</article-title>
            <source>Heliyon</source>
            <year>2019</year>
            <month>May</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>e01783</fpage>
            <pub-id pub-id-type="pmid">31193734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mathian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bachelot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hervier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Haroche</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boutin-Le Thi Huong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Costedoat-Chalumeau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Karmali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Velkeniers</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Touraine</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Coussieu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bennani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renard-Penna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grenier</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Wahl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Amoura</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>98</volume>
            <issue>8</issue>
            <fpage>3179</fpage>
            <page-range>3179-89</page-range>
            <pub-id pub-id-type="pmid">23783099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mwamure</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nirmalaraj</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Addison's disease in a patient with hypothyroidism: autoimmune polyglandular syndrome type 2.</article-title>
            <source>BMJ Case Rep</source>
            <year>2015</year>
            <month>Aug</month>
            <day>03</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">26240101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puttanna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Dainty</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Addison's disease and its associations.</article-title>
            <source>BMJ Case Rep</source>
            <year>2013</year>
            <month>Jul</month>
            <day>26</day>
            <volume>2013</volume>
            <pub-id pub-id-type="pmid">23893277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sapolsky</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Munck</surname>
                <given-names>AU</given-names>
              </name>
            </person-group>
            <article-title>How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions.</article-title>
            <source>Endocr Rev</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-89</page-range>
            <pub-id pub-id-type="pmid">10696570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malbon</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Rapiejko</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Watkins</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Permissive hormone regulation of hormone-sensitive effector systems.</article-title>
            <source>Trends Pharmacol Sci</source>
            <year>1988</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-6</page-range>
            <pub-id pub-id-type="pmid">3072728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turnbull</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Rivier</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Regulation of the HPA axis by cytokines.</article-title>
            <source>Brain Behav Immun</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>253</fpage>
            <page-range>253-75</page-range>
            <pub-id pub-id-type="pmid">8903845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellavance</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rivest</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain.</article-title>
            <source>Front Immunol</source>
            <year>2014</year>
            <volume>5</volume>
            <fpage>136</fpage>
            <pub-id pub-id-type="pmid">24744759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pariante</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Pisell</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Po</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function.</article-title>
            <source>Endocrinology</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>140</volume>
            <issue>9</issue>
            <fpage>4359</fpage>
            <page-range>4359-66</page-range>
            <pub-id pub-id-type="pmid">10465310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quatrini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ugolini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>New insights into the cell-&#x000a0;and tissue-specificity of glucocorticoid actions.</article-title>
            <source>Cell Mol Immunol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-278</page-range>
            <pub-id pub-id-type="pmid">32868909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erkut</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Pool</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Swaab</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>83</volume>
            <issue>6</issue>
            <fpage>2066</fpage>
            <page-range>2066-73</page-range>
            <pub-id pub-id-type="pmid">9626140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Summer</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Schrier</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Role of glucocorticoid hormones in arginine vasopressin gene regulation.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>2001</year>
            <month>Dec</month>
            <day>21</day>
            <volume>289</volume>
            <issue>5</issue>
            <fpage>1252</fpage>
            <page-range>1252-6</page-range>
            <pub-id pub-id-type="pmid">11741329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>McQueen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Regulation of Glucose Homeostasis by Glucocorticoids.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2015</year>
            <volume>872</volume>
            <fpage>99</fpage>
            <page-range>99-126</page-range>
            <pub-id pub-id-type="pmid">26215992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sominsky</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Eating behavior and stress: a pathway to obesity.</article-title>
            <source>Front Psychol</source>
            <year>2014</year>
            <volume>5</volume>
            <fpage>434</fpage>
            <pub-id pub-id-type="pmid">24860541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bollag</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Regulation of aldosterone synthesis and secretion.</article-title>
            <source>Compr Physiol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>1017</fpage>
            <page-range>1017-55</page-range>
            <pub-id pub-id-type="pmid">24944029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esposito</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pasquali</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Johannsson</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Feb</month>
            <day>01</day>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>376</fpage>
            <page-range>376-387</page-range>
            <pub-id pub-id-type="pmid">29156052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Claessen</surname>
                <given-names>KMJA</given-names>
              </name>
              <name>
                <surname>Andela</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Biermasz</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>701365</fpage>
            <pub-id pub-id-type="pmid">34354671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dineen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Sherlock</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adrenal crisis: prevention and management in adult patients.</article-title>
            <source>Ther Adv Endocrinol Metab</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>2042018819848218</fpage>
            <pub-id pub-id-type="pmid">31223468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shahid</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Vella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Importance of a thorough drug history in presurgical patients.</article-title>
            <source>BMJ Case Rep</source>
            <year>2014</year>
            <month>Mar</month>
            <day>14</day>
            <volume>2014</volume>
            <pub-id pub-id-type="pmid">24632903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinsen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baslund</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klose</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Friis-Hansen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hilsted</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Feldt-Rasmussen</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself.</article-title>
            <source>Eur J Intern Med</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>714</fpage>
            <page-range>714-20</page-range>
            <pub-id pub-id-type="pmid">23806261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hopkins</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Leinung</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Exogenous Cushing's syndrome and glucocorticoid withdrawal.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>371</fpage>
            <page-range>371-84, ix</page-range>
            <pub-id pub-id-type="pmid">15850848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazlauskaite</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Villabona</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Abdu</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Ambrosi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Atkinson</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Clayton</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Courtney</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Gonc</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Maghnie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Soule</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Tordjman</surname>
                <given-names>K</given-names>
              </name>
              <collab>Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency</collab>
            </person-group>
            <article-title>Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>11</issue>
            <fpage>4245</fpage>
            <page-range>4245-53</page-range>
            <pub-id pub-id-type="pmid">18697868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oelkers</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Oct</month>
            <day>17</day>
            <volume>335</volume>
            <issue>16</issue>
            <fpage>1206</fpage>
            <page-range>1206-12</page-range>
            <pub-id pub-id-type="pmid">8815944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malikova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fl&#x000fc;ck</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Novel insight into etiology, diagnosis and management of primary adrenal insufficiency.</article-title>
            <source>Horm Res Paediatr</source>
            <year>2014</year>
            <volume>82</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-57</page-range>
            <pub-id pub-id-type="pmid">25096886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prete</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Bancos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kohler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fazal-Sanderson</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Komninos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Neil</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Vassiliadi</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Mowatt</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Mihai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fallowfield</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lord</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Keevil</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Wass</surname>
                <given-names>JAH</given-names>
              </name>
              <name>
                <surname>Karavitaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2020</year>
            <month>Jul</month>
            <day>01</day>
            <volume>105</volume>
            <issue>7</issue>
            <fpage>2262</fpage>
            <page-range>2262-74</page-range>
            <pub-id pub-id-type="pmid">32170323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guignat</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic patient education in adrenal insufficiency.</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-173</page-range>
            <pub-id pub-id-type="pmid">29606279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenker</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Skatrud</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency in critically ill patients.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>163</volume>
            <issue>7</issue>
            <fpage>1520</fpage>
            <page-range>1520-3</page-range>
            <pub-id pub-id-type="pmid">11401866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Betterle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Presotto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Furmaniak</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>12</issue>
            <fpage>1407</fpage>
            <page-range>1407-1433</page-range>
            <pub-id pub-id-type="pmid">31321757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ngaosuwan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Godsland</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Majeed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Quint</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Increased Mortality Risk in Patients With Primary and Secondary Adrenal Insufficiency.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2021</year>
            <month>Jun</month>
            <day>16</day>
            <volume>106</volume>
            <issue>7</issue>
            <fpage>e2759</fpage>
            <page-range>e2759-e2768</page-range>
            <pub-id pub-id-type="pmid">33596308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <collab>Society for Endocrinology Clinical Committee</collab>
            </person-group>
            <article-title>SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients.</article-title>
            <source>Endocr Connect</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>G1</fpage>
            <page-range>G1-G3</page-range>
            <pub-id pub-id-type="pmid">27935813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodcock</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wass</surname>
                <given-names>JAH</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Dattani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vercueil</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK.</article-title>
            <source>Anaesthesia</source>
            <year>2020</year>
            <month>May</month>
            <volume>75</volume>
            <issue>5</issue>
            <fpage>654</fpage>
            <page-range>654-663</page-range>
            <pub-id pub-id-type="pmid">32017012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burger-Stritt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kardonski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pulzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Quinkler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-29</page-range>
            <pub-id pub-id-type="pmid">29617051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsubayashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakatake</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Possible adrenal insufficiency among fatigue patients in a psychosomatic medical clinic.</article-title>
            <source>Endocr J</source>
            <year>2020</year>
            <month>Jan</month>
            <day>28</day>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-57</page-range>
            <pub-id pub-id-type="pmid">31597820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17224.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>A retrospective analysis of adrenal crisis in steroid-dependent patients: causes, frequency and outcomes.</article-title>
            <source>BMC Endocr Disord</source>
            <year>2019</year>
            <month>Dec</month>
            <day>02</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <pub-id pub-id-type="pmid">31791297</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
